Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China · Delayed Price · Currency is CNY 31.91
-0.27 (-0.84%)
Aug 31, 2026, 3:04 PM CST
SHE:002294 Market Cap
SHE:002294 has a market cap or net worth of 35.66 billion as of August 31, 2026. Its market cap has decreased by -36.46% in one year.
Market Cap
35.66B
Enterprise Value
33.91B
Revenue
4.70B
Ranking
n/a
PE Ratio
53.66
Stock Price
31.91
ChartMarket Cap Chart
Since September 10, 2009, SHE:002294's market cap has increased from 5.64B to 35.66B, an increase of 532.37%. That is a compound annual growth rate of 11.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 35.66B | -35.44% |
| Dec 31, 2025 | 55.24B | 60.20% |
| Dec 31, 2024 | 34.48B | -3.26% |
| Dec 29, 2023 | 35.64B | -1.61% |
| Dec 30, 2022 | 36.23B | 19.87% |
| Dec 31, 2021 | 30.22B | 3.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huadong Medicine | 48.51B |
| China Resources Sanjiu Medical & Pharmaceutical | 40.59B |
| Beijing Tongrentang | 33.57B |
| Dong-E-E-Jiao | 31.35B |
| Changchun High-Tech Industry (Group) | 30.50B |
| Humanwell Healthcare (Group) | 30.46B |
| Dizal (Jiangsu) Pharmaceutical | 27.29B |
| Shijiazhuang Yiling Pharmaceutical | 27.03B |